Navigation Links
Avalon Pharmaceuticals to Present at the American Association for,Cancer Research 2007 Annual Meeting

e monosphospate dehydrogenase (IMPDH), an enzyme that is critical for cells to be able to synthesize guanosine triphosphate (GTP), a molecule required for DNA synthesis and cellular signaling. IMPDH is over expressed in some cancer cells, especially in the case of hematological malignancies. In laboratory experiments, AVN944 has been shown to inhibit IMPDH activity in cells, and suppress pools of GTP. Anticancer activities of IMPDH inhibitors correlate with sustained depletion of GTP pools both in cellular models and in human subjects. AVN944 appears to have a selective effect on cancer cells in that deprivation of GTP in normal cells results in a temporary slowing of cell growth, while GTP deprivation in cancer cells induces cell death, or apoptosis. Results from preclinical studies of AVN944 indicate that AVN944 inhibited the proliferation of lymphoid and myeloid cells, the principal cells involved in the most common types of human leukemias. In a single-dose, dose- escalation phase I clinical trial of AVN944 conducted in the United Kingdom in healthy volunteers, AVN944: (1) was well tolerated at all tested doses with no notable side effects; (2) demonstrated good pharmacokinetic properties; and (3) had a significant inhibitory effect on IMPDH enzyme activity. Avalon filed an IND with the FDA in August 2005 and initiated U.S. phase I clinical trials in January 2006 for the treatment of hematological cancers.

Avalon Pharmaceuticals is a biopharmaceutical company using its proprietary technology, AvalonRx(R), to discover and develop cancer therapeutics. Avalon has a lead product in Phase I clinical development (AVN944 - IMPDH inhibitor), as well as preclinical programs to discover inhibitors for the beta-catenin and aurora pathways now in late stage lead candidate optimization. Avalon also has discovery programs on modulators of survivin function and a drug discovery program targeting the MYC oncoprotein, one of the most important and previously intractable c
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Avalon Pharmaceuticals Announces Positive Interim Results For AVN944 Phase I Trial
2. Avalon Updates the AVN944 Phase I Hematologic Malignancies Trial
3. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
7. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
8. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
9. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
10. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
11. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
Post Your Comments:
(Date:8/26/2014)... Aug. 26, 2014 Acelleron Medical Products of ... N.J ., is expanding.  Acelleron, a home medical equipment ... new division, Acelleron Maternal Health & Wellness (MHW), to offer ... a full range of resources for pregnant women and families. ... the director of maternal wellness. Vecchi, the former owner of ...
(Date:8/26/2014)... , Aug. 26, 2014  Sorrento Therapeutics, Inc. ... clinical oncology company developing new treatments for cancer ... has received funding to advance an immunotherapy targeting ... of IPF, which affects more than 100,000 Americans. ... increases and patients gradually lose the ability to ...
(Date:8/26/2014)... 2014  Based on its recent analysis of the breast ... the 2014 North American Frost & Sullivan Award for Technology ... breast imaging solutions for the early detection of breast cancer. ... several new solutions and has expanded its global reach to ... Europe , Asia and ...
Breaking Medicine Technology:Suzanne Vecchi Named Director of Newly Acquired Acelleron Maternal Health & Wellness 2Sorrento Awarded NIH Grant to Advance Immunotherapy Targeting Idiopathic Pulmonary Fibrosis (IPF) 2Sorrento Awarded NIH Grant to Advance Immunotherapy Targeting Idiopathic Pulmonary Fibrosis (IPF) 3Frost & Sullivan Applauds Volpara Solutions' Clear Vision in Identifying the Importance of Dose Tracking and Quantitative Analytics in the Early Detection of Breast Cancer 2Frost & Sullivan Applauds Volpara Solutions' Clear Vision in Identifying the Importance of Dose Tracking and Quantitative Analytics in the Early Detection of Breast Cancer 3Frost & Sullivan Applauds Volpara Solutions' Clear Vision in Identifying the Importance of Dose Tracking and Quantitative Analytics in the Early Detection of Breast Cancer 4Frost & Sullivan Applauds Volpara Solutions' Clear Vision in Identifying the Importance of Dose Tracking and Quantitative Analytics in the Early Detection of Breast Cancer 5
... , New collaborative research program to study effects on ... 30 A new research program called the Medication Exposure ... study the effects of prescription medications used during pregnancy. The ... Administration and researchers at the HMO Research Network Center for ...
... Dec. 30 For the twelfth consecutive year, Rev. Nicholas ... campaigning to save lives during New Year,s Eve celebrations. ... Health Alliance Plan (HAP) and the Wayne County Sheriff,s Office, ... New Year without gunfire. The hope is that there ...
Cached Medicine Technology:FDA, Health Organizations to Study Safety of Medications Taken During Pregnancy 2FDA, Health Organizations to Study Safety of Medications Taken During Pregnancy 3Rev. Nick Hood, III Asks Southeast Michiganders Not to Use Guns During New Year's Eve Celebrations 2
(Date:8/27/2014)... August 27, 2014 ALS Insights is ... optimism and comfort. It features a series of compelling ... ALS. They share their insights, in searing honesty, about ... the impact on children, what happened in the final ... Bucket Challenge has created a dramatic increase in public ...
(Date:8/27/2014)... 2014 Inspira Marketing Group ... to go the distance this September by logging their ... Run. Walk. Ride. initiative, hosted by Alex’s Lemonade Stand ... childhood cancer. September represents National Childhood Cancer Awareness ... Inspira Marketing Group has teamed up with event founder ...
(Date:8/27/2014)... A recently published study ... time in correcting coagulopathy to prevent permanent injury or ... anticoagulants and examines medical conditions alleged to be caused ... anticoagulants have been approved by the FDA to reduce ... also known to affect the consistency of the anticoagulation ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 In My Solitude, ... Candle Collection” to provide a growing number of women from ... tool for goal setting and relaxing at the same time. ... candles, uses scent memory and visualization to help women stay ... life each time they light a candle and enjoy the ...
(Date:8/27/2014)... North Carolina (PRWEB) August 27, 2014 ... did so by necessity when no-one would join her on ... try canyoneering – an extreme sport involving ropes, harnesses and ... my first experience with solo travel but definitely not my ... years, having adventures that pushed me to the edge, and ...
Breaking Medicine News(10 mins):Health News:ALS Insights Launched as Web Resource of Interviews and Information 2Health News:Alex’s Lemonade Stand Foundation Kicks Off Alex’s Million Mile – Run. Walk. Ride. with Labor Day 5k Run in New York City’s Hudson River Park 2Health News:Alex’s Lemonade Stand Foundation Kicks Off Alex’s Million Mile – Run. Walk. Ride. with Labor Day 5k Run in New York City’s Hudson River Park 3Health News:Flood Law Group Comments on Recent AAICH Study 2Health News:In My Solitude Unveils Eco Candle Line That May Improve Performance 2Health News:Best-selling Author Janice Holly Booth Offers Tips to Navigating Fear and Living a Fuller Life 2
... AIDS Hospice Now Serves as HIV/AIDS Care Hub, ... its filing of a lawsuit against the City of ... breach of contract and for a,"judicial determination" regarding the ... the US, largest non-profit HIV/AIDS,healthcare, research, prevention and education ...
... food labels , , SUNDAY, Feb. 24 (HealthDay News) -- ... can improve your heart health, but also your overall ... to be guided toward healthier choices for your heart, ... Cathy Fitzgerald, registered dietitian with MFit, the University of ...
... to the Lesbian, Gay, Bisexual and Transgender ... (LGBT) Movement By Early Microsoft Employee Pride ... Pride Foundation of Seattle is honored,to announce the establishment ... Mr. Weiland,s gift of $65 million is the largest single ...
... likely to have an attack, study finds , , SATURDAY, ... factors and more barriers to health care may be among ... States than in Europe, a new study suggests. , Researchers ... and 30,120 people in 11 European countries, and found that ...
... improving patient safety and enabling better information management for ... caregivers and patients., ORLANDO, Fla., Feb. 22 , ... (HIMSS) 2008 Conference & Exhibition, ... showcase in its booth (No. 2247) new solutions designed ...
... users diagnosed almost 7 years earlier than nonsmokers , , ... with significant exposure to secondhand smoke should start getting ... than the current recommended age of 50, a new ... Medical Center in New York analyzed the cases of ...
Cached Medicine News:Health News:AHF Sues L.A. Housing Dept. to Prevent Closure of AIDS Site 2Health News:AHF Sues L.A. Housing Dept. to Prevent Closure of AIDS Site 3Health News:AHF Sues L.A. Housing Dept. to Prevent Closure of AIDS Site 4Health News:AHF Sues L.A. Housing Dept. to Prevent Closure of AIDS Site 5Health News:How to Be Heart Smart at the Supermarket 2Health News:Ric Weiland Leaves $65 Million to Support Gay Rights and HIV/AIDS Organizations 2Health News:Ric Weiland Leaves $65 Million to Support Gay Rights and HIV/AIDS Organizations 3Health News:More Risk Factors, Less Access to Care Behind Higher Stroke Rates in U.S. 2Health News:Microsoft to Showcase Innovative Solutions for Healthcare Providers and Consumers at HIMSS 2008 Annual Conference & Exhibition 2Health News:Microsoft to Showcase Innovative Solutions for Healthcare Providers and Consumers at HIMSS 2008 Annual Conference & Exhibition 3Health News:Earlier Colon Cancer Screens Urged for Smokers 2
... The Px2 Thermal Cycler is Thermo ... machine to date with easy to use ... display for easy programming. Designed to offer ... the Px2 incorporates a number of customer ...
... Advanced Design With Exceptional Performance ... user interface might be the ... the MyCycler is designed for ... at a premium, its small ...
96 well thermocycler with unique High Temperature Range (HTR) Peltier technology for fastest available heating and cooling rates up to 4C/sec with High Pressure Lid for automated sealing of PCR plate...
... speeds, highest precision, more user-friendliness and absolute ... is the definition of the Mastercycler ep ... acid research has been developing dynamically. The ... PCR Systems. To keep pace with ...
Medicine Products: